SK
OREX

Seth Klarman’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Seth Klarman’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,226,839
Closed -$465K – 38
2018
Q1 		$465K Hold
2,226,839
– – ﹤0.01% 33
2017
Q4 		$2.87M Hold
2,226,839
– – 0.03% 33
2017
Q3 		$4.72M Hold
2,226,839
– – 0.06% 34
2017
Q2 		$6.46M Hold
2,226,839
– – 0.07% 38
2017
Q1 		$7.66M Hold
2,226,839
– – 0.09% 40
2016
Q4 		$3.88M Hold
2,226,839
– – 0.05% 42
2016
Q3 		$7.39M Sell
2,226,839
-1
-0% -$4 0.11% 39
2016
Q2 		$9.57M Hold
2,226,840
– – 0.13% 36
2016
Q1 		$12.5M Buy
2,226,840
+2,000,000
+882% +$26M 0.18% 30
2015
Q4 		$3.9M Buy
226,840
+144,704
+176% +$3.45M 0.07% 34
2015
Q3 		$1.53M Buy
+82,136
New +$2.81M 0.03% 41

Other funds holding OREX

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Seth Klarman's OREX Position: Q2 2018 in Review

Seth Klarman sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 2,226,839 shares — an estimated $465K sold.

Seth Klarman first reported a position in OREX in Q3 2015 and held it in 11 quarters. The position peaked at $12.5M in Q1 2016. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

  • Seth Klarman reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Seth Klarman sold 2,226,839 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $465K.
  • Seth Klarman first reported a position in Orexigen Therapeutics, Inc. in Q3 2015 and held it in 11 quarters.
  • Seth Klarman's Orexigen Therapeutics, Inc. position peaked at $12.5M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Baupost Group's 13F filing for Q2 2018, filed 13 Aug 2018.